BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3381557)

  • 1. Changes with age in leucocyte counts, protein and IgG content of lumbar cerebrospinal fluid (CSF) of patients with inflammatory, ischemic, and hemorrhagic diseases or tumors of the central nervous system (CNS).
    Kleine TO; Weber L; Zöfel P
    Z Gerontol; 1988; 21(2):102-5. PubMed ID: 3381557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG.
    Bartosik-Psujek H; Archelos JJ
    J Neurol; 2004 Apr; 251(4):414-20. PubMed ID: 15083285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immuneglobulin investigations in inflammatory diseases.
    Schmidt RM; Lange U
    Schweiz Arch Neurol Neurochir Psychiatr; 1976; 119(1):43-8. PubMed ID: 62392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport and production of cerebrospinal fluid (CSF) change in aging humans under normal and diseased conditions.
    Kleine TO; Hackler R; Lütcke A; Dauch W; Zöfel P
    Z Gerontol; 1993; 26(4):251-5. PubMed ID: 8212795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid (CSF) parameters and clinical course of multiple sclerosis.
    Livrea P; Simone IL; Trojano M; Pisicchio L; Logroscino G; Rosato A
    Riv Neurol; 1987; 57(3):189-96. PubMed ID: 3672011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].
    Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z
    Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Albumin and IGG in the CSF as demonstration of blood-brain barrier damage and of immune response within the CNS (author's transl)].
    Cognazzo A; Gerbino Promis PC; Grasso E
    Riv Patol Nerv Ment; 1981; 101(3):151-64. PubMed ID: 7256113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgM, IgA and IgG producing cells in cerebrospinal fluid and peripheral blood in multiple sclerosis.
    Henriksson A; Kam-Hansen S; Link H
    Clin Exp Immunol; 1985 Oct; 62(1):176-84. PubMed ID: 4064372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use and abuse of the cerebrospinal fluid IgG profile in the adult: a practical evaluation.
    Hershey LA; Trotter JL
    Ann Neurol; 1980 Oct; 8(4):426-34. PubMed ID: 6776879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Patho-physiological aspects in csf proteins (author's transl)].
    Glasner H
    Dtsch Med Wochenschr; 1975 Aug; 100(32):1630-3. PubMed ID: 51712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in cerebrospinal fluid immunoglobulin serial parameters in neurologic disorders].
    Wang WZ; Zhou YK
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Feb; 22(1):12-6, 61. PubMed ID: 2805971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The diagnostic value of immunoglobulin G in the cerebrospinal fluid of brain tumor patients, particularly in malignant tumors].
    Onodera Y; Saitoh Y; Nagai K
    Gan No Rinsho; 1987 Oct; 33(12):1402-6. PubMed ID: 3682191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the minimal amount of IgG synthesized within the central nervous system in different neurological diseases.
    Kerényi L; Koltai M; Pálffy G
    Acta Med Acad Sci Hung; 1979; 36(4):367-73. PubMed ID: 122042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Multiple Sclerosis Cooperative Etiological Study in Italy: preliminary analysis of CSF findings.
    Trojano M; Logroscino GC; Pisicchio L; Rosato A; Bordo B; Citterio A; Amato MP; Livrea P
    Ital J Neurol Sci; 1987 Jun; Suppl 6():71-6. PubMed ID: 3654180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral spinal fluid IgG production in HIV-positive patients.
    Cirelli A; Ciardi M; Rossi F
    Recenti Prog Med; 1989 Mar; 80(3):150-2. PubMed ID: 2740604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Questioning the role of actinfree Gc-Globulin as actin scavenger in neurodegenerative central nervous system disease: relationship to S-100B levels and blood-brain barrier function.
    Gressner OA; Schifflers MC; Kim P; Heuts L; Lahme B; Gressner AM
    Clin Chim Acta; 2009 Feb; 400(1-2):86-90. PubMed ID: 19000909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid protein findings during prophylaxis and treatment of neuromeningosis in leukaemic patients.
    Marra R; Pagano L; Storti S; Massaro A; Teofili L; Carbone G; Leone G
    Scand J Clin Lab Invest; 1987 Dec; 47(8):765-9. PubMed ID: 3432998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of anti-coronavirus antibody testing of cerebrospinal fluid for diagnosis of feline infectious peritonitis involving the central nervous system in cats.
    Boettcher IC; Steinberg T; Matiasek K; Greene CE; Hartmann K; Fischer A
    J Am Vet Med Assoc; 2007 Jan; 230(2):199-205. PubMed ID: 17223751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activin A concentrations in human cerebrospinal fluid are age-dependent and elevated in meningitis.
    Ebert S; Phillips DJ; Jenzewski P; Nau R; O'Connor AE; Michel U
    J Neurol Sci; 2006 Dec; 250(1-2):50-7. PubMed ID: 16920154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.